Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

10 projects found matching your search criteria :

  1. Therapeutic potential of an FGF21 analogue in HFpEF: targeting cardiac, skeletal muscle, and cognitive function to impro...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Maria Katarzyna Głowienka-Stodolak

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  2. Molecular insights into NAD+ metabolism in Huntington's disease: role in pathophysiology and preclinical assessment of t...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: dr hab. Marta Urszula Tomczyk

    Gdański Uniwersytet Medyczny

  3. Exploring DMRTA2 in Glioblastoma: Epigenetic Regulation, Angiogenesis Disruption, and Biomarker Development

    Call: SONATA BIS 14 , Panel: NZ3

    Principal investigator: dr Marta Magdalena Maleszewska-Bobińska

    Uniwersytet Warszawski

  4. Targeting IGH enhancer RNAs as a therapeutic approach in B-cell lymphoma

    Call: SONATA BIS 13 , Panel: NZ1

    Principal investigator: dr hab. Agnieszka Dzikiewicz-Krawczyk

    Instytut Genetyki Człowieka PAN

  5. Targeting undruggable proteins involved in tumorigenesis – developing and characterization of advanced nanoplatform for ...

    Call: OPUS 25 , Panel: NZ6

    Principal investigator: dr hab. Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Bitechnologii

  6. Targeting of metabolic and transcriptomic cross-talk between leukemic cells and macrophages as a therapeutic strategy in...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Baran Natalia

    Instytut Hematologii i Transfuzjologii

  7. Targeting UDP-glucose and P2Y14 receptor interaction for therapeutic modulation of inflammatory lung diseases

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Tadeusz Piotr Karcz

    Uniwersytet Jagielloński, Collegium Medicum

  8. Targeting of HSF1 as a therapeutic approach to inhibit the progression of hormone-dependent breast cancer.

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Natalia Vydra

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  9. Identification and therapeutic targeting of the mRNA splicing alteration mechanisms driven by gain-of-function TP53 muta...

    Call: SONATA 17 , Panel: NZ5

    Principal investigator: dr Magdalena Oroń

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  10. Modulation mitochondrial metabolism and dynamics and tageting DNA methylation of adipose derived mesenchymal stromal ste...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Krzysztof Marycz

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Biologii i Hodowli Zwierząt